Spironolactone reduces brachial pulse wave velocity and PIIINP levels in hypertensive diabetic patients

J. Davies, A. Gavin, M. Band, A. Morris, A. Struthers

    Research output: Contribution to journalArticle

    26 Citations (Scopus)

    Abstract

    To assess whether spironolactone has beneficial effects on blood pressure (BP), N-terminal propeptide of type III procollagen (PIIINP) and pulse wave velocity (PWV) in hypertensive, type II diabetics.
    Original languageEnglish
    Pages (from-to)520-3
    Number of pages4
    JournalBritish Journal of Clinical Pharmacology
    Volume59
    Issue number5
    DOIs
    Publication statusPublished - May 2005

    Fingerprint

    Pulse Wave Analysis
    Spironolactone
    Collagen Type III
    Arm
    Blood Pressure
    procollagen Type III-N-terminal peptide

    Cite this

    @article{07012a7001dc4b0d889cbfcaf4aaed6d,
    title = "Spironolactone reduces brachial pulse wave velocity and PIIINP levels in hypertensive diabetic patients",
    abstract = "To assess whether spironolactone has beneficial effects on blood pressure (BP), N-terminal propeptide of type III procollagen (PIIINP) and pulse wave velocity (PWV) in hypertensive, type II diabetics.",
    author = "J. Davies and A. Gavin and M. Band and A. Morris and A. Struthers",
    year = "2005",
    month = "5",
    doi = "10.1111/j.1365-2125.2005.02363.x",
    language = "English",
    volume = "59",
    pages = "520--3",
    journal = "British Journal of Clinical Pharmacology",
    issn = "0306-5251",
    publisher = "Wiley",
    number = "5",

    }

    Spironolactone reduces brachial pulse wave velocity and PIIINP levels in hypertensive diabetic patients. / Davies, J.; Gavin, A.; Band, M.; Morris, A.; Struthers, A.

    In: British Journal of Clinical Pharmacology, Vol. 59, No. 5, 05.2005, p. 520-3.

    Research output: Contribution to journalArticle

    TY - JOUR

    T1 - Spironolactone reduces brachial pulse wave velocity and PIIINP levels in hypertensive diabetic patients

    AU - Davies, J.

    AU - Gavin, A.

    AU - Band, M.

    AU - Morris, A.

    AU - Struthers, A.

    PY - 2005/5

    Y1 - 2005/5

    N2 - To assess whether spironolactone has beneficial effects on blood pressure (BP), N-terminal propeptide of type III procollagen (PIIINP) and pulse wave velocity (PWV) in hypertensive, type II diabetics.

    AB - To assess whether spironolactone has beneficial effects on blood pressure (BP), N-terminal propeptide of type III procollagen (PIIINP) and pulse wave velocity (PWV) in hypertensive, type II diabetics.

    U2 - 10.1111/j.1365-2125.2005.02363.x

    DO - 10.1111/j.1365-2125.2005.02363.x

    M3 - Article

    VL - 59

    SP - 520

    EP - 523

    JO - British Journal of Clinical Pharmacology

    JF - British Journal of Clinical Pharmacology

    SN - 0306-5251

    IS - 5

    ER -